Study results show CAR T-cell therapy improves survival for adults with large B-cell lymphoma who did not respond well to or relapsed after, the first line of treatment. Learn about CAR T-cell therapy for large B-cell lymphoma from Dr. Joseph McGuirk, medical director of the blood and marrow transplant program at The University of Kansas Cancer Center.
